Avantor® Announces Board Chairman Transition
Avantor (NYSE: AVTR) announced a chairman transition: independent director Gregory L. Summe will become Chairman of the Board effective January 1, 2026. Current Chairman Jonathan Peacock will step down as chairman and as a director at the end of 2025 after nearly nine years of service.
Since joining the board in 2020, Mr. Summe has chaired the Nominating and Governance Committee and served on the Compensation Committee. The company referenced its recent CEO change to Emmanuel Ligner and the addition of Greg Lucier to the board as part of its current governance composition.
Avantor (NYSE: AVTR) ha annunciato una transizione della presidenza: il consigliere indipendente Gregory L. Summe diventerà Presidente del Consiglio di Amministrazione con effetto 1 gennaio 2026. L'attuale Presidente Jonathan Peacock si dimetterà dalla carica di presidente e da consigliere entro la fine del 2025 dopo quasi nove anni di servizio.
Da quando si è unito al consiglio nel 2020, il signor Summe ha presieduto il Comitato Nomination e Governance e ha fatto parte del Comitato per la Retribuzione. L'azienda ha fatto riferimento al recente cambio di CEO a Emmanuel Ligner e all'aggiunta di Greg Lucier al consiglio come parte della governance attuale.
Avantor (NYSE: AVTR) anunció una transición de presidente: el director independiente Gregory L. Summe se convertirá en Presidente del Consejo de Administración a partir del 1 de enero de 2026. El actual Presidente Jonathan Peacock dejará su cargo como presidente y como director a finales de 2025, tras casi nueve años de servicio.
Desde que se unió al consejo en 2020, el Sr. Summe ha presidido el Comité de Nombramientos y Gobernanza y formó parte del Comité de Compensación. La compañía hizo referencia a su reciente cambio de CEO a Emmanuel Ligner y a la incorporación de Greg Lucier al consejo como parte de la composición de gobernanza actual.
Avantor(NYSE: AVTR)는 의장 이양을 발표했습니다: 독립 이사 Gregory L. Summe가 2026년 1월 1일을 기점으로 이사회 의장이 됩니다. 현재 의장 Jonathan Peacock은 2025년 말 끝으로 의장직과 이사직에서 물러날 예정입니다. 9년 가까운 근무 기간.
2020년 이사회에 합류한 이후, Summe 회장은 후보 선임 및 거버넌스 위원회를 이끌었고 보상 위원회에서 근무했습니다. 회사는 Emmanuel Ligner의 CEO 교체와 이사회에 Greg Lucier의 합류를 현 거버넌스 구성의 일부로 언급했습니다.
Avantor (NYSE: AVTR) a annoncé une transition du président: le directeur indépendant Gregory L. Summe deviendra Président du Conseil d'Administration à compter du 1er janvier 2026. L'actuel Président Jonathan Peacock quittera ses fonctions de président et de directeur à la fin de l'année 2025 après près de neuf ans de service.
Depuis son entrée au conseil en 2020, M. Summe a présidé le Comité de nomination et de gouvernance et a siégé au Comité de la rémunération. L'entreprise a évoqué son récent changement de PDG avec Emmanuel Ligner et l'ajout de Greg Lucier au conseil dans le cadre de la composition actuelle de la gouvernance.
Avantor (NYSE: AVTR) gab eine Vorsitzwechsel bekannt: Der unabhängige Direktor Gregory L. Summe wird ab dem 1. Januar 2026 Vorsitzender des Vorstands. Der aktuelle Vorsitzende Jonathan Peacock wird zum Ende des Jahres 2025 nach fast neun Jahren im Amt als Vorsitzender und als Direktor zurücktreten.
Seit seinem Eintritt in den Vorstand im Jahr 2020 hat Herr Summe den Ausschuss für Nominierung und Governance geleitet und im Vergütungsausschuss gesessen. Das Unternehmen verwies auf den jüngsten CEO-Wechsel zu Emmanuel Ligner und die Aufnahme von Greg Lucier in den Vorstand als Teil der gegenwärtigen Governance-Struktur.
أنتوفير (رمزها في بورصة نيويورك: AVTR) أعلن عن انتقال الرئيس: من المرتقب أن يصبح المدير المستقل جريجوري إل. سُمّ رئيس مجلس الإدارة اعتباراً من 1 يناير 2026. سيتنحى الرئيس الحالي جوناثان بوتريك عن منصبه كرئيس وكعضو مجلس الإدارة في نهاية عام 2025 بعد ما يقرب من تسع سنوات من الخدمة.
منذ انضمامه إلى المجلس في 2020، ترأس السيد سُمّ لجنة الترشيحات والحوكمة وكان عضواً في لجنة التعويضات. أشارت الشركة إلى تغير المدير التنفيذي الأخير إلى إيمانويل ليينجر وإضافة جريج لوسير إلى المجلس كجزء من تشكيل الحوكمة الحالي.
Avantor（NYSE: AVTR） 宣布了 董事长交接：独立董事 Gregory L. Summe 将于 2026年1月1日 起成为董事会主席。现任主席 Jonathan Peacock 将在2025年底前辞去主席职务并退出董事会，任职近九年。
自2020年加入董事会以来，Summe先生一直担任提名与治理委员会主席，并担任薪酬委员会成员。公司提及最近的CEO变动至 Emmanuel Ligner，以及将 Greg Lucier 纳入董事会，作为当前治理结构的一部分。
- Chair transition effective Jan 1, 2026
- Greg Summe served on board since 2020
- Summe chaired the Nominating and Governance Committee
- Jonathan Peacock to step down as chairman and director end of 2025
Gregory L. Summe to Serve as Next Chairman of the Board Beginning on January 1, 2026
Jonathan Peacock to Step Down After Nearly Nine Years of Dedicated Service to the Board
Since joining the Avantor Board in 2020, Mr. Summe has served as Chairman of the Nominating and Governance Committee and as a member of the Compensation Committee. Mr. Summe is a highly experienced CEO and Board member in the Tools and Life Sciences sector.
Mr. Peacock said, "It has been a privilege to serve as Avantor's Chairman and to work alongside my Board colleagues in managing the Company's transition to a new CEO and in building its position as a Life Sciences leader. With Emmanuel Ligner as our new CEO and with the addition of Greg Lucier to our Board, this is the right moment for new Board leadership. The Avantor Board comprises talented, experienced leaders with a wide range of backgrounds and expertise in life sciences. I am confident that with their guidance and Emmanuel's leadership, Avantor will realize its potential and deliver strong shareholder returns."
"Having served on the Board for the past five years, I've seen firsthand the talent across Avantor," said Mr. Summe. "I look forward to working closely with my fellow Board members, Emmanuel, and the entire leadership team as we continue executing our strategy to deliver growth and profitability across the business."
Mr. Summe continued, "On behalf of the Board, I also want to express our deep appreciation to Jon for his strong leadership of the Board, managing the transition to our new CEO, and his unwavering commitment to Avantor."
About Avantor
Avantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedIn, X (Twitter) and Facebook.
Forward-Looking and Cautionary Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and are subject to the safe harbor created thereby under the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release are forward-looking statements. Forward-looking statements discuss our current expectations and projections relating to our financial condition, results of operations, plans, including our cost transformation initiative, objectives, future performance and business. These statements may be preceded by, followed by or include the words "aim," "anticipate," "assumption," "believe," "continue," "estimate," "expect," "forecast," "goal," "guidance," "intend," "likely," "long-term," "near-term," "objective," "opportunity," "outlook," "plan," "potential," "project," "projection," "prospects," "seek," "target," "trend," "can," "could," "may," "should," "would," "will," the negatives thereof and other words and terms of similar meaning.
Forward-looking statements are inherently subject to risks, uncertainties and assumptions; they are not guarantees of performance. You should not place undue reliance on these statements. We have based these forward-looking statements on our current expectations and projections about future events. Although we believe that our assumptions made in connection with the forward-looking statements are reasonable, we cannot assure you that the assumptions and expectations will prove to be correct. Factors that could contribute to these risks, uncertainties and assumptions include, but are not limited to, the factors described in "Risk Factors" in our most recent Annual Report on Form 10-K, and subsequent quarterly reports on Form 10-Q, as such risk factors may be updated from time to time in our periodic filings with the SEC.
All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the foregoing cautionary statements. In addition, all forward-looking statements speak only as of the date of this press release. We undertake no obligations to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise other than as required under the federal securities laws.
Investor Relations Contact
Allison Hosak
Senior Vice President, Global Communications
Avantor
908-329-7281
Allison.Hosak@avantorsciences.com
Media Contact
Eric Van Zanten
Head of External Communications
Avantor
610-529-6219
Eric.Vanzanten@avantorsciences.com
View original content:https://www.prnewswire.com/news-releases/avantor-announces-board-chairman-transition-302582232.html
SOURCE Avantor and Financial News
FAQ
When will Gregory L. Summe become Avantor chairman (AVTR)?
When is Jonathan Peacock leaving Avantor's board (AVTR)?
What roles has Greg Summe held on the Avantor board (AVTR)?
Does the Avantor announcement mention CEO changes related to the board shift (AVTR)?
What is the effective date of Avantor's board leadership change (AVTR)?
